These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30998329)

  • 41. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents.
    Doğanlar O; Doğanlar ZB; Kurtdere AK; Chasan T; Ok ES
    Ecotoxicol Environ Saf; 2020 Oct; 202():110940. PubMed ID: 32800223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein.
    Freshney RI
    Br J Cancer; 2007 Dec; 97(12):1714; author reply 1715. PubMed ID: 17987034
    [No Abstract]   [Full Text] [Related]  

  • 45. Resveratrol-mediated reversal of tumor multi-drug resistance.
    Hu Y; Li C; Li H; Li M; Shu X
    Curr Drug Metab; 2014; 15(7):703-10. PubMed ID: 25255872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
    De Vera AA; Gupta P; Lei Z; Liao D; Narayanan S; Teng Q; Reznik SE; Chen ZS
    Cancer Lett; 2019 Feb; 442():91-103. PubMed ID: 30391357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rituximab but not other anti-CD20 antibodies reverses multidrug resistance in 2 B lymphoma cell lines, blocks the activity of P-glycoprotein (P-gp), and induces P-gp to translocate out of lipid rafts.
    Ghetie MA; Crank M; Kufert S; Pop I; Vitetta E
    J Immunother; 2006; 29(5):536-44. PubMed ID: 16971809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity.
    Mollazadeh S; Sahebkar A; Kalalinia F; Behravan J; Hadizadeh F
    Bioorg Chem; 2019 Oct; 91():103156. PubMed ID: 31416030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein.
    Stefan K; Schmitt SM; Wiese M
    J Med Chem; 2017 Nov; 60(21):8758-8780. PubMed ID: 29016119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
    Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
    [No Abstract]   [Full Text] [Related]  

  • 51. Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance.
    Yuan H; Li X; Wu J; Li J; Qu X; Xu W; Tang W
    Curr Med Chem; 2008; 15(5):470-6. PubMed ID: 18289002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
    Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
    Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3,5-dibenzoyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells.
    Kawase M; Shah A; Gaveriya H; Motohashi N; Sakagami H; Varga A; Molnár J
    Bioorg Med Chem; 2002 Apr; 10(4):1051-5. PubMed ID: 11836114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new insight into the reversal of multidrug resistance in cancer by nanodrugs.
    Jiang H; Guo D; Chen D; Wu Y; Jin X; Zhu X
    Biomater Sci; 2019 Aug; 7(8):3489-3496. PubMed ID: 31282916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
    Lee CH
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.
    Waghray D; Zhang Q
    J Med Chem; 2018 Jun; 61(12):5108-5121. PubMed ID: 29251920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
    Wong IL; Wang BC; Yuan J; Duan LX; Liu Z; Liu T; Li XM; Hu X; Zhang XY; Jiang T; Wan SB; Chow LM
    J Med Chem; 2015 Jun; 58(11):4529-49. PubMed ID: 25985195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
    Dinić J; Podolski-Renić A; Jeremić M; Pešić M
    Curr Pharm Des; 2018; 24(36):4334-4354. PubMed ID: 30648503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.